INGN
Inogen, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$5.42
−0.55%Margins
Gross margin
48.9%
EBITDA margin
-1.9%
EBIT margin
-8.4%
Net margin
-6.9%
FCF margin
-2.7%
-14.1%
Return on equity
-8.6%
Return on assets
-15.7%
Return on invested capital
1.24x
Asset turnover
-$2.5M
Cash from operations
$3.98
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026